NEA Management Company as of March 31, 2024
Portfolio Holdings for NEA Management Company
NEA Management Company holds 44 positions in its portfolio as reported in the March 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Arcellx Common Stock (ACLX) | 16.2 | $261M | 3.7M | 69.55 | |
| Crispr Therapeutics Namen Akt (CRSP) | 11.2 | $180M | 1.6M | 113.62 | |
| Rhythm Pharmaceuticals (RYTM) | 7.8 | $126M | 2.9M | 43.33 | |
| Savara (SVRA) | 7.6 | $122M | 25M | 4.98 | |
| Coursera (COUR) | 6.7 | $108M | 13M | 8.41 | |
| Korro Bio (KRRO) | 6.0 | $97M | 1.1M | 90.00 | |
| Verona Pharma Sponsered Ads (VRNA) | 5.6 | $90M | 5.1M | 17.59 | |
| Monte Rosa Therapeutics (GLUE) | 3.4 | $54M | 7.7M | 7.05 | |
| Nextnav Common Stock (NN) | 3.3 | $54M | 8.2M | 6.58 | |
| CVRX (CVRX) | 2.7 | $43M | 2.4M | 18.21 | |
| Geron Corporation (GERN) | 2.6 | $42M | 13M | 3.30 | |
| Trevi Therapeutics (TRVI) | 2.4 | $39M | 11M | 3.45 | |
| Nkarta (NKTX) | 2.4 | $39M | 3.6M | 10.81 | |
| Celcuity (CELC) | 1.7 | $27M | 1.3M | 21.60 | |
| Adaptimmune Therapeutics Sponds Adr (ADAP) | 1.7 | $27M | 17M | 1.58 | |
| Black Diamond Therapeutics (BDTX) | 1.4 | $23M | 4.4M | 5.07 | |
| X4 Pharmaceuticals (XFOR) | 1.3 | $21M | 15M | 1.39 | |
| Phathom Pharmaceuticals (PHAT) | 1.3 | $21M | 2.0M | 10.62 | |
| Oric Pharmaceuticals (ORIC) | 1.3 | $21M | 1.5M | 13.75 | |
| ZeroFox Holdings | 1.3 | $20M | 18M | 1.12 | |
| Aurinia Pharmaceuticals (AUPH) | 1.2 | $20M | 4.0M | 5.01 | |
| Gossamer Bio (GOSS) | 1.2 | $19M | 16M | 1.18 | |
| Inozyme Pharma (INZY) | 1.2 | $19M | 2.4M | 7.66 | |
| Regulus Therapeutics | 1.2 | $19M | 6.5M | 2.88 | |
| Neuehealth Com New (NEUE) | 1.1 | $18M | 2.7M | 6.50 | |
| Desktop Metal Com Cl A | 0.8 | $13M | 14M | 0.88 | |
| Glycomimetics (GLYC) | 0.7 | $12M | 3.8M | 3.00 | |
| Sagimet Biosciences Com Ser A (SGMT) | 0.7 | $11M | 2.0M | 5.42 | |
| Tuya Sponsered Ads (TUYA) | 0.5 | $8.6M | 4.9M | 1.75 | |
| Champions Oncology Com New (CSBR) | 0.5 | $8.4M | 1.7M | 4.90 | |
| Reneo Pharmaceuticals (RPHM) | 0.5 | $7.9M | 4.8M | 1.66 | |
| Allakos (ALLK) | 0.5 | $7.7M | 6.1M | 1.26 | |
| Buzzfeed Class A Com | 0.4 | $7.2M | 15M | 0.47 | |
| Lexicon Pharmaceuticals Com New (LXRX) | 0.4 | $5.7M | 2.4M | 2.40 | |
| Inventiva Sa Ads (IVA) | 0.3 | $5.3M | 1.5M | 3.62 | |
| Synlogic Com New (SYBX) | 0.3 | $5.2M | 2.9M | 1.79 | |
| Marker Therapeutics Com New (MRKR) | 0.3 | $4.6M | 1.1M | 4.30 | |
| Affimed Nv Ordinary Shs New (AFMD) | 0.1 | $2.3M | 443k | 5.30 | |
| Senti Biosciences Ord (SNTI) | 0.1 | $1.7M | 4.4M | 0.38 | |
| Mynd Ai Spon Ads (MYND) | 0.1 | $1.6M | 3.6M | 0.43 | |
| Xeris Pharmaceuticals (XERS) | 0.1 | $926k | 419k | 2.21 | |
| Ikena Oncology (IKNA) | 0.1 | $810k | 570k | 1.42 | |
| Wheels Up Experience Com Cl A (UP) | 0.0 | $305k | 106k | 2.87 | |
| Surf Air Mobility (SRFM) | 0.0 | $186k | 220k | 0.84 |
